Download PDF
As the coronavirus crisis continues to have a devasting impact on people’s lives and livelihoods, all eyes are on scientists to deliver on a COVID-19 vaccine. It is widely accepted that a safe and effective vaccine represents our best chance of …
The debate over a rapid but safe and effective vaccine to fight the COVID-19 pandemic has heated up in Europe and worldwide.
The EU's fragmented market has created barriers for vaccines in Europe. In this Special Report, EURACTIV looks into what a “healthy vaccines ecosystem” is and how its different components could better coordinate to break silos and improve healthcare.
The rise of anti-vaccination campaigns has in recent years had a detrimental effect on EU public health as “forgotten” diseases such as measles re-appeared in Europe, raising eyebrows among policymakers.
An increase in vaccine hesitancy, combined with the insufficient preparedness of EU member state healthcare systems against infectious diseases, has raised eyebrows in Brussels and the EU capitals, which now seek ways to minimise outbreak risks.
